Medical - Devices
Compare Stocks
2 / 10Stock Comparison
DHAI vs ENVA
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Credit Services
DHAI vs ENVA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Financial - Credit Services |
| Market Cap | $51K | $4.36B |
| Revenue (TTM) | $63M | $3.15B |
| Net Income (TTM) | $-9M | $327M |
| Gross Margin | 51.0% | 50.1% |
| Operating Margin | -7.7% | 23.5% |
| Forward P/E | — | 10.6x |
| Total Debt | $12M | $4.56B |
| Cash & Equiv. | $2M | $72M |
DHAI vs ENVA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 24 | Apr 26 | Return |
|---|---|---|---|
| DIH Holding US, Inc. (DHAI) | 100 | 0.2 | -99.8% |
| Enova International… (ENVA) | 100 | 248.5 | +148.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DHAI vs ENVA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DHAI is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta -1.21, current ratio 0.49x
- Beta -1.21, current ratio 0.49x
ENVA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 18.6%, EPS growth 55.9%
- 20.6% 10Y total return vs DHAI's -99.9%
- 18.6% NII/revenue growth vs DHAI's -2.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.6% NII/revenue growth vs DHAI's -2.5% | |
| Quality / Margins | 9.8% margin vs DHAI's -13.8% | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +84.1% vs DHAI's -99.3% | |
| Efficiency (ROA) | 5.2% ROA vs DHAI's -32.4% |
DHAI vs ENVA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
DHAI vs ENVA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ENVA leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENVA is the larger business by revenue, generating $3.2B annually — 50.1x DHAI's $63M. ENVA is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to DHAI's -13.8%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $63M | $3.2B |
| EBITDAEarnings before interest/tax | -$4M | $815M |
| Net IncomeAfter-tax profit | -$9M | $327M |
| Free Cash FlowCash after capex | -$5M | $1.9B |
| Gross MarginGross profit ÷ Revenue | +51.0% | +50.1% |
| Operating MarginEBIT ÷ Revenue | -7.7% | +23.5% |
| Net MarginNet income ÷ Revenue | -13.8% | +9.8% |
| FCF MarginFCF ÷ Revenue | -7.4% | +56.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -27.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +22.6% | +28.6% |
Valuation Metrics
DHAI leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $50,711 | $4.4B |
| Enterprise ValueMkt cap + debt − cash | $10M | $8.9B |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | 15.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 10.64x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 11.33x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 1.38x |
| Price / BookPrice ÷ Book value/share | — | 3.45x |
| Price / FCFMarket cap ÷ FCF | — | 2.46x |
Profitability & Efficiency
ENVA leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), ENVA scores 6/9 vs DHAI's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +24.9% |
| ROA (TTM)Return on assets | -32.4% | +5.2% |
| ROICReturn on invested capital | — | +10.4% |
| ROCEReturn on capital employed | — | +13.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | — | 3.41x |
| Net DebtTotal debt minus cash | $10M | $4.5B |
| Cash & Equiv.Liquid assets | $2M | $72M |
| Total DebtShort + long-term debt | $12M | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | -21.37x | 79.01x |
Total Returns (Dividends Reinvested)
ENVA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENVA five years ago would be worth $47,424 today (with dividends reinvested), compared to $9 for DHAI. Over the past 12 months, ENVA leads with a +84.1% total return vs DHAI's -99.3%. The 3-year compound annual growth rate (CAGR) favors ENVA at 59.7% vs DHAI's -90.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +837.5% | +8.0% |
| 1-Year ReturnPast 12 months | -99.3% | +84.1% |
| 3-Year ReturnCumulative with dividends | -99.9% | +307.6% |
| 5-Year ReturnCumulative with dividends | -99.9% | +374.2% |
| 10-Year ReturnCumulative with dividends | -99.9% | +2064.6% |
| CAGR (3Y)Annualised 3-year return | -90.3% | +59.7% |
Risk & Volatility
Evenly matched — DHAI and ENVA each lead in 1 of 2 comparable metrics.
Risk & Volatility
DHAI is the less volatile stock with a -1.21 beta — it tends to amplify market swings less than ENVA's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ENVA currently trades 99.0% from its 52-week high vs DHAI's 0.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -1.21x | 1.48x |
| 52-Week HighHighest price in past year | $8.99 | $176.68 |
| 52-Week LowLowest price in past year | $0.00 | $89.00 |
| % of 52W HighCurrent price vs 52-week peak | +0.3% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 38.1 | 65.3 |
| Avg Volume (50D)Average daily shares traded | 2K | 224K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $199.50 |
| # AnalystsCovering analysts | — | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.9% |
ENVA leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DHAI leads in 1 (Valuation Metrics). 1 tied.
DHAI vs ENVA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is DHAI or ENVA a better buy right now?
For growth investors, Enova International, Inc.
(ENVA) is the stronger pick with 18. 6% revenue growth year-over-year, versus -2. 5% for DIH Holding US, Inc. (DHAI). Enova International, Inc. (ENVA) offers the better valuation at 15. 1x trailing P/E (10. 6x forward), making it the more compelling value choice. Analysts rate Enova International, Inc. (ENVA) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — DHAI or ENVA?
Over the past 5 years, Enova International, Inc.
(ENVA) delivered a total return of +374. 2%, compared to -99. 9% for DIH Holding US, Inc. (DHAI). Over 10 years, the gap is even starker: ENVA returned +20. 6% versus DHAI's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — DHAI or ENVA?
By beta (market sensitivity over 5 years), DIH Holding US, Inc.
(DHAI) is the lower-risk stock at -1. 21β versus Enova International, Inc. 's 1. 48β — meaning ENVA is approximately -222% more volatile than DHAI relative to the S&P 500.
04Which is growing faster — DHAI or ENVA?
By revenue growth (latest reported year), Enova International, Inc.
(ENVA) is pulling ahead at 18. 6% versus -2. 5% for DIH Holding US, Inc. (DHAI). On earnings-per-share growth, the picture is similar: Enova International, Inc. grew EPS 55. 9% year-over-year, compared to 24. 1% for DIH Holding US, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — DHAI or ENVA?
Enova International, Inc.
(ENVA) is the more profitable company, earning 9. 8% net margin versus -13. 8% for DIH Holding US, Inc. — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENVA leads at 23. 5% versus -7. 7% for DHAI. At the gross margin level — before operating expenses — DHAI leads at 51. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — DHAI or ENVA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is DHAI or ENVA better for a retirement portfolio?
For long-horizon retirement investors, DIH Holding US, Inc.
(DHAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1. 21)). Both have compounded well over 10 years (DHAI: -99. 9%, ENVA: +20. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between DHAI and ENVA?
These companies operate in different sectors (DHAI (Healthcare) and ENVA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DHAI is a small-cap quality compounder stock; ENVA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.